• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number ECH060040
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Obstruction/Occlusion (2422); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/08/2021
Event Type  Injury  
Manufacturer Narrative
As the device remains implanted, a further investigation on the device cannot be performed.It was requested if the thrombus is available to be sent back for further investigation.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
It was reported to gore that patient underwent surgical treatment on (b)(6) 2021 for a centralization of a loop shunt with gore-tex® interponat with end-to-side anastomosis at the axillary artery and end-to-end anastomosis at the cephalic vein on the proximal upper arm with a gore® acuseal vascular graft.It was stated that on (b)(6) 2021 there was an acute loop shunt occlusion at the axillary artery and cephalic vein (upper arm) left because of an extensive stenosis of the cephalic vein.To solve the issue a thrombectomy of the loop-shunt and an extension of the venous limb on the brachial vein at the proximal upper arm left was performed.It was reported that the patient has tolerated the procedure.
 
Manufacturer Narrative
Product history review: a review of the manufacturing records indicated the lots met all pre-release specifications.Explant investigation of the returned thrombus a tissue fragment was returned to w.L.Gore & associates for investigation.Submitted in formalin was a tissue fragment that had been reportedly removed via thrombectomy from an implanted gore acuseal vascular graft.The fragment was tan to dark brown, linear soft tissue, in a tubular/luminal cast of tissue.The fragment measured approximately 90 mm (length) x 3-6 mm (diameter).The specimen was submitted for histopathologic sampling.Tissue preservation was poor with marked loss of stain/cellular differentiation.Fibrin deposition with varying reorganization and infiltration by minute inflammation within the lumen of the gore acuseal vascular graft was typical and an expected normal healing response to a chronically implanted device.It is uncertain if cannulation interaction may have induced infiltration of the external fibrous connective tissue to the unorganized luminal thrombus, which after time becomes organized into fibrous connective tissue (i.E., neointima).
 
Manufacturer Narrative
Product history review: a review of the sterilization records indicated the lots met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12346898
MDR Text Key267410938
Report Number2017233-2021-02292
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/14/2023
Device Catalogue NumberECH060040
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/14/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexMale
-
-